Related Experiment Video
Updated: May 4, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Is nighttime blood pressure important in cardiovascular risk assessment in coronary atherosclerosis?
W Sobiczewski1, M Wirtwein2, M Gruchala1
1I Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
Insights
Elevated nighttime blood pressure (BP) is linked to increased major adverse cardiac events (MACE) in hypertensive patients with coronary atherosclerosis. Monitoring nocturnal BP may improve cardiovascular risk assessment in this population.
Area of Science:
- Cardiology
- Hypertension Research
- Preventive Cardiology
Background:
- Nighttime blood pressure (BP) is crucial for cardiovascular risk assessment in the general population.
- The prognostic significance of elevated nighttime BP in hypertensive patients with established coronary atherosclerosis remains unclear.
- The PROGNOSIS study investigated the association between abnormal nighttime BP and major adverse cardiac events (MACE) in this specific patient group.
Discussion:
- A higher prevalence of abnormal nighttime BP (≥120/70 mmHg) was observed in patients who experienced MACE compared to those who did not.
- Cumulative incidence curves indicated a significantly higher risk of MACE during the follow-up period for individuals with abnormal nighttime BP.
- These findings suggest that elevated nighttime BP is an independent contributor to cardiovascular risk in patients with confirmed coronary atherosclerosis.
Key Insights:
- Abnormal nighttime BP is more prevalent in hypertensive patients with coronary atherosclerosis who experience MACE.
- Hypertensive patients with coronary atherosclerosis and elevated nighttime BP face a greater risk of MACE.
- Nighttime BP monitoring can be a valuable tool for risk stratification in patients with coronary artery disease.
Outlook:
- Further research is warranted to elucidate the mechanisms underlying the association between nighttime BP and MACE.
- Integrating nighttime BP monitoring into routine clinical practice may enhance cardiovascular risk prediction in patients with coronary atherosclerosis.
- Investigating therapeutic strategies targeting nighttime hypertension could potentially reduce MACE in this vulnerable population.
Abstract:
Elevated nighttime blood pressure (BP) values have a pivotal role in cardiovascular risk assessment in the general population. However, the role of elevated nighttime BP in hypertensive patients with established coronary atherosclerosis is unknown. In the PROGNOSIS (Prognostic Value of Ambulatory Blood Pressure Monitoring in Patients with Coronary Artery Disease Confirmed by Angiography) study, we evaluated the relationship between abnormal nighttime BP and major adverse cardiac events (MACE) over a median 6.6-year observation period of hypertensive subjects with coronary atherosclerosis established by coronary angiography. There was a higher prevalence of abnormal nighttime BP (defined as mean nighttime BP values > or = 120/70 mmHg) in patients with MACE than those without MACE (58% vs. 48%, P < 0.01). The curves of cumulative incidence revealed a higher risk of MACE in subjects with abnormal nighttime BP than in those without nighttime hypertension during the follow-up period. Our findings might indicate that nighttime BP contribute to increased cardiovascular risk in subjects with coronary atherosclerosis established by coronary angiography.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
04:44Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Measurement of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Coronary Artery Disease I: Introduction